The Organisation of Pharmaceutical Producers of India (OPPI) recently hosted its flagship Annual Summit 2026 at Shangri-La Eros, New Delhi, bringing together senior government officials, regulators, industry leaders, academia and healthcare stakeholders to discuss India's next phase of pharmaceutical growth. Centered around the theme ‘Power of Partnerships’, the Summit celebrated OPPI's 60 years of engagement with India's healthcare ecosystem.
Amitabh Dube, President – OPPI and Country President and Managing Director, Novartis India said, “India has established strong foundations in pharmaceutical manufacturing, talent and science. The opportunity ahead is to build on these strengths and move towards greater innovation, research and high-value capabilities. This transition will require partnerships across government, industry, academia and the wider healthcare ecosystem. As OPPI celebrates 60 years, the theme ‘Power of Partnerships’ reflects the collective effort needed to advance India's pharmaceutical ambitions.”
Anil Matai, Director General, OPPI said, “India's pharmaceutical ambitions require an ecosystem that supports research, encourages investment and provides regulatory predictability. Timely access to innovative medicines and stronger research capabilities will be important to this journey. The three publications launched at the Summit bring together perspectives on India's healthcare ambitions, the evolving role of Pharma GCCs and Regulatory Data Protection. OPPI remains committed to constructive engagement with policymakers and stakeholders to advance these priorities, keeping patients and better health outcomes at the centre.”
A key highlight was the launch of three publications addressing India's pharmaceutical ambitions: OPPI at 60: The Power of Partnerships – Powering India's Healthcare Century: Driving Innovation, Resilience and Better Health Outcomes; Pharma GCCs: Powering India's Next Growth Frontier; and Advancing Pharmaceutical Innovation in India through Regulatory Data Protection.
From Volume to Value: Partnerships Shaping the Future of Indian Pharmaceuticals; examines India's transition from the ‘Pharmacy of the World’ to an innovation-led healthcare leader. The report also outlines a partnership agenda towards Viksit Bharat @2047, built around four outcomes: better health for more people, resilient and trusted health systems, innovation-led economic value and global healthcare leadership.
Pharma GCCs: Powering India's Next Growth Frontier; examines the evolution of Global Capability Centres from scaled delivery operations to strategic enterprise capabilities. It notes that India hosts more than half of the world's GCC base. The report highlights the expanding role of Pharma GCCs across discovery, clinical development, safety, regulatory, medical, market access, commercial, manufacturing and supply functions.
Advancing Pharmaceutical Innovation in India through Regulatory Data Protection: Innovation and Patient Access; examines the role of RDP in supporting pharmaceutical innovation. It explains how RDP differs from patents, focusing on the protection of proprietary test and clinical trial data submitted to regulators to establish a medicine's safety and efficacy for marketing approval.
The Summit also featured addresses by senior government and regulatory stakeholders and a panel discussion on ‘Power of Partnerships’, bringing together perspectives from across the pharmaceutical and healthcare ecosystem.
Senior government and regulatory stakeholders also mentioned the time lag between global and Indian launches of new medicines has reduced from around 4–5 years earlier to approximately six months or less in recent cases.
The OPPI Awards 2026 recognised contributions to science, healthcare and innovation.
|
Award category |
Awardee |
|
OPPI Lifetime Achievement Award 2026 |
Dr Habil F Khorakiwala |
|
OPPI Special Recognition Award 2026 |
Prof. (Dr) Balram Bhargava |
|
OPPI Scientist of the Year 2026 |
Prof. Aravind Penmatsa, Associate Professor, Molecular Biophysics Unit, Indian Institute of Science, Bangalore |
|
OPPI Woman Scientist of the Year 2026 |
Prof. Swati Biswas, Professor, Birla Institute of Technology & Science, Pilani |
|
OPPI Young Scientist of the Year 2026 |
Dr Jogender Singh, Assistant Professor, IISER, Mohali |
|
OPPI Excellence in Innovation Award for Healthcare Start-up of the Year 2026 |
Qure.ai |